Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Capricor will reverse-merge with Nile in a stock deal. Nile will issue Capricor stockholders shares of Nile stock so
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury